STOCK TITAN

Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Alpine Immune Sciences, Inc. (ALPN) will participate in two upcoming healthcare conferences, the Guggenheim 6th Annual Biotechnology Conference and the Oppenheimer 34th Annual Healthcare Life Sciences Conference. The Company will host investor meetings and fireside chats during the events, with live webcasts and replays available on the Company's website.
Positive
  • None.
Negative
  • None.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences.

  • Thursday, February 8th, the Company will participate in a fireside chat at 10:00 am ET/7:00 am PT during the Guggenheim 6th Annual Biotechnology Conference in New York, NY and host investor meetings the same day.
  • Wednesday, February 14th, the Company will participate in a fireside chat during the virtual Oppenheimer 34th Annual Healthcare Life Sciences Conference at 12:00 pm ET/9:00 am PT and host investor meetings the same day.

Live webcasts of the fireside chats will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and a replay will be available on the Company's website for 90 days following the event.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on X and LinkedIn.

Media and Investor Relations Contact:

Temre Johnson

Alpine Immune Sciences, Inc.

ir@alpineimmunesciences.com

media@alpineimmunesciences.com

Source: Alpine Immune Sciences, Inc.

FAQ

When will Alpine Immune Sciences participate in the Guggenheim 6th Annual Biotechnology Conference?

Alpine Immune Sciences will participate in the Guggenheim 6th Annual Biotechnology Conference on Thursday, February 8th.

What time will the fireside chat at the Guggenheim 6th Annual Biotechnology Conference start?

The fireside chat at the Guggenheim 6th Annual Biotechnology Conference will start at 10:00 am ET/7:00 am PT.

Where can I watch the live webcast of the fireside chats?

The live webcasts of the fireside chats will be available in the investor relations section of Alpine Immune Sciences' website at https://ir.alpineimmunesciences.com/events.

Alpine Immune Sciences, Inc.

NASDAQ:ALPN

ALPN Rankings

ALPN Latest News

ALPN Stock Data

4.24B
44.92M
4.64%
91.41%
8.06%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
SEATTLE

About ALPN

founded in 2015 by a team responsible for the fda's approval of the world's first cancer immunotherapy and experts in the field of recombinant protein based immunotherapies, alpine immune sciences was created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer, autoimmune disorders, and other diseases. traded on nasdaq under ticker alpn.